Animal models for arrhythmias

Cardiovascular Research

Volumn 67, Issue 3, 2005, Pages 426-437

  Milan, David J ^b   MacRae, Calum A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

Arrhythmias; Drugs; Genetics; Modeling

Indexed keywords

ACCURACY; ARRHYTHMOGENESIS; ATRIOVENTRICULAR BLOCK; BRUGADA SYNDROME; CONGESTIVE CARDIOMYOPATHY; CORRELATION ANALYSIS; CYTOLOGY; DISEASE MODEL; DRUG INDUCED DISEASE; ENVIRONMENTAL FACTOR; EXCITABILITY; EXPERIMENTAL MODEL; FEASIBILITY STUDY; GENE; GENE MUTATION; GENETIC MODEL; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART MUSCLE EXCITABILITY; HEART MUSCLE ISCHEMIA; HEART REPOLARIZATION; HEART VENTRICLE TACHYCARDIA; HYPERTROPHIC CARDIOMYOPATHY; KNOCKOUT MOUSE; LONG QT SYNDROME; MEMBRANE; MOLECULAR BIOLOGY; MUTATION; NERVE CONDUCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REPOLARIZATION; REVIEW; SIGNAL TRANSDUCTION; SINUS NODE; SUDDEN DEATH; SYNDROME; TRANSGENIC ANIMAL; TRANSGENIC MOUSE;

ANIMALS; ARRHYTHMIA; DISEASE MODELS, ANIMAL; HEART CONDUCTION SYSTEM; MODELS, ANIMAL; ORGANISMS, GENETICALLY MODIFIED; RESEARCH;

EID: 22544471264     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cardiores.2005.06.012     Document Type: Review

References (117)

1. P.M. Spooner, C. Albert, E.J. Benjamin, R. Boineau, R.C. Elston, and A.L. George Jr. Sudden cardiac death, genes, and arrhythmogenesis:consideration of new population and mechanistic approaches from a national heart, lung, and blood institute workshop, part I Circulation 103 2001 2361 2364
2. M.T. Keating, and M.C. Sanguinetti Molecular and cellular mechanisms of cardiac arrhythmias Cell 104 2001 569 580
3. T.J. Jentsch, C.A. Hubner, and J.C. Fuhrmann Ion channels: function unravelled by dysfunction Nat Cell Biol 6 2004 1039 1047
4. E. Ficker, A.T. Dennis, L. Wang, and A.M. Brown Role of the cytosolic chaperones Hsp70 and Hsp90 in maturation of the cardiac potassium channel HERG Circ Res 92 2003 e87 e100
5. R.S. Kass, J. Kurokawa, S.O. Marx, and A.R. Marks Leucine/isoleucine zipper coordination of ion channel macromolecular signaling complexes in the heart. Roles in inherited arrhythmias Trends Cardiovasc Med 13 2003 52 56
6. M.J. Berridge, M.D. Bootman, and H.L. Roderick Calcium signalling: dynamics, homeostasis and remodelling Nat Rev Mol Cell Biol 4 2003 517 529
7. V.M. Christoffels, J.B. Burch, and A.F. Moorman Architectural plan for the heart: early patterning and delineation of the chambers and the nodes Trends Cardiovasc Med 14 2004 301 307
8. C. Antzelevitch, and J. Fish Electrical heterogeneity within the ventricular wall Basic Res Cardiol 96 2001 517 527
9. J.M. de Bakker, F.J. van Capelle, M.J. Janse, A.A. Wilde, R. Coronel, and A.E. Becker Reentry as a cause of ventricular tachycardia in patients with chronic ischemic heart disease: electrophysiologic and anatomic correlation Circulation 77 1988 589 606
10. R.L. Verrier, and C. Antzelevitch Autonomic aspects of arrhythmogenesis: the enduring and the new Curr Opin Cardiol 19 2004 2 11
11. A. Frustaci, C. Chimenti, F. Bellocci, E. Morgante, M.A. Russo, and A. Maseri Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
12. D.M. Roden Drug-induced prolongation of the QT interval N Engl J Med 350 2004 1013 1022
13. L. Eckardt, W. Haverkamp, M. Borggrefe, and G. Breithardt Experimental models of torsade de pointes Cardiovasc Res 39 1998 178 193
14. S. Nattel New ideas about atrial fibrillation 50 years on Nature 415 2002 219 226
15. M. Allessie, J. Ausma, and U. Schotten Electrical, contractile and structural remodeling during atrial fibrillation Cardiovasc Res 54 2002 230 246
16. A.L. Waldo Mechanisms of atrial fibrillation J Cardiovasc Electrophysiol 14 2003 S267 S274
17. J.G. Seidman, and C. Seidman The genetic basis for cardiomyopathy: from mutation identification to mechanistic paradigms Cell 104 2001 557 567
18. C.I. Berul, M.E. Christe, M.J. Aronovitz, C.E. Seidman, J.G. Seidman, and M.E. Mendelsohn Electrophysiological abnormalities and arrhythmias in alpha MHC mutant familial hypertrophic cardiomyopathy mice J Clin Invest 99 1997 570 576
19. V.V. Patel, M. Arad, I.P. Moskowitz, C.T. Maguire, D. Branco, and J.G. Seidman Electrophysiologic characterization and postnatal development of ventricular pre-excitation in a mouse model of cardiac hypertrophy and Wolff-Parkinson-White syndrome J Am Coll Cardiol 42 2003 942 951
20. P.J. Mohler, J.J. Schott, A.O. Gramolini, K.W. Dilly, S. Guatimosim, and W.H. duBell Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death Nature 421 2003 634 639
21. M.C. Casimiro, B.C. Knollmann, S.N. Ebert, J.C. Vary Jr., A.E. Greene, and M.R. Franz Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome Proc Natl Acad Sci U S A 98 2001 2526 2531
22. M.C. Casimiro, B.C. Knollmann, E.N. Yamoah, L. Nie, J.C. Vary Jr., and S.G. Sirenko Targeted point mutagenesis of mouse Kcnq1: phenotypic analysis of mice with point mutations that cause Romano-Ward syndrome in humans Genomics 84 2004 555 564
23. D. Nuyens, M. Stengl, S. Dugarmaa, T. Rossenbacker, V. Compernolle, and Y. Rudy Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome Nat Med 7 2001 1021 1027
24. A. Ludwig, T. Budde, J. Stieber, S. Moosmang, C. Wahl, and K. Holthoff Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2 Embo J 22 2003 216 224
25. J. Stieber, S. Herrmann, S. Feil, J. Loster, R. Feil, and M. Biel The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart Proc Natl Acad Sci U S A 100 2003 15235 15240
26. N.S. Moise Inherited arrhythmias in the dog: potential experimental models of cardiac disease Cardiovasc Res 44 1999 37 46
27. A.E. Buckley, J. Dean, and I.R. Mahy Cardiac involvement in Emery Dreifuss muscular dystrophy: a case series Heart 82 1999 105 108
28. M.A. Allessie, P.A. Boyden, A.J. Camm, A.G. Kleber, M.J. Lab, and M.J. Legato Pathophysiology and prevention of atrial fibrillation Circulation 103 2001 769 777
29. J. Jalife, O. Berenfeld, A. Skanes, and R. Mandapati Mechanisms of atrial fibrillation: mother rotors or multiple daughter wavelets, or both? J Cardiovasc Electrophysiol 9 1998 S2 S12
30. R. Mandapati, A. Skanes, J. Chen, O. Berenfeld, and J. Jalife Stable microreentrant sources as a mechanism of atrial fibrillation in the isolated sheep heart Circulation 101 2000 194 199
31. M. Haissaguerre, P. Jais, D.C. Shah, A. Takahashi, M. Hocini, and G. Quiniou Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins N Engl J Med 339 1998 659 666
32. J. Ausma, N. Litjens, M.H. Lenders, H. Duimel, F. Mast, and L. Wouters Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat J Mol Cell Cardiol 33 2001 2083 2094
33. L. Yue, J. Feng, R. Gaspo, G.R. Li, Z. Wang, and S. Nattel Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation Circ Res 81 1997 512 525
34. R. Gaspo, R.F. Bosch, M. Talajic, and S. Nattel Functional mechanisms underlying tachycardia-induced sustained atrial fibrillation in a chronic dog model Circulation 96 1997 4027 4035
35. R.F. Bosch, and S. Nattel Cellular electrophysiology of atrial fibrillation Cardiovasc Res 54 2002 259 269
36. L. Yue, P. Melnyk, R. Gaspo, Z. Wang, and S. Nattel Molecular mechanisms underlying ionic remodeling in a dog model of atrial fibrillation Circ Res 84 1999 776 784
37. J. Ausma, G.D. Dispersyn, H. Duimel, F. Thone, L. Ver Donck, and M.A. Allessie Changes in ultrastructural calcium distribution in goat atria during atrial fibrillation J Mol Cell Cardiol 32 2000 355 364
38. U. Schotten, M. Greiser, D. Benke, K. Buerkel, B. Ehrenteidt, and C. Stellbrink Atrial fibrillation-induced atrial contractile dysfunction: a tachycardiomyopathy of a different sort Cardiovasc Res 53 2002 192 201
39. V.L. Thijssen, H.M. van der Velden, E.P. van Ankeren, J. Ausma, M.A. Allessie, and M. Borgers Analysis of altered gene expression during sustained atrial fibrillation in the goat Cardiovasc Res 54 2002 427 437
40. M.C. Wijffels, C.J. Kirchhof, R. Dorland, and M.A. Allessie Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
41. R.G. Tieleman, C. De Langen, I.C. Van Gelder, P.J. de Kam, J. Grandjean, and K.J. Bel Verapamil reduces tachycardia-induced electrical remodeling of the atria Circulation 95 1997 1945 1953
42. S. Nattel, A. Shiroshita-Takeshita, S. Cardin, and P. Pelletier Mechanisms of atrial remodeling and clinical relevance Curr Opin Cardiol 20 2005 21 25
43. J.L. Cox, R.B. Schuessler, H.J. D'Agostino Jr., C.M. Stone, B.C. Chang, and M.E. Cain The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure J Thorac Cardiovasc Surg 101 1991 569 583
44. P. Jais, M. Hocini, L. Macle, K.J. Choi, I. Deisenhofer, and R. Weerasooriya Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation Circulation 106 2002 2479 2485
45. J. Jalife Experimental and clinical AF mechanisms: bridging the divide J Interv Card Electrophysiol 9 2003 85 92
46. C.A. Morillo, G.J. Klein, D.L. Jones, and C.M. Guiraudon Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation Circulation 91 1995 1588 1595
47. J.E. Olgin, and S. Verheule Transgenic and knockout mouse models of atrial arrhythmias Cardiovasc Res 54 2002 280 286
48. C.S. Hong, M.C. Cho, Y.G. Kwak, C.H. Song, Y.H. Lee, and J.S. Lim Cardiac remodeling and atrial fibrillation in transgenic mice overexpressing junctin Faseb J 16 2002 1310 1312
49. S. Verheule, T. Sato, T.T. Everett, S.K. Engle, D. Otten, and M. Rubart-von der Lohe Increased vulnerability to atrial fibrillation in transgenic mice with selective atrial fibrosis caused by overexpression of TGF-beta1 Circ Res 94 2004 1458 1465
50. H.D. Xiao, S. Fuchs, D.J. Campbell, W. Lewis, S.C. Dudley Jr., and V.S. Kasi Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death Am J Pathol 165 2004 1019 1032
51. J. Li, M. McLerie, and A.N. Lopatin Transgenic upregulation of IK1 in the mouse heart leads to multiple abnormalities of cardiac excitability Am J Physiol Heart Circ Physiol 287 2004 H2790 H2802
52. P.T. Ellinor, and C.A. Macrae The genetics of atrial fibrillation J Cardiovasc Electrophysiol 14 2003 1007 1009
53. W.Y. Huang, J. Aramburu, P.S. Douglas, and S. Izumo Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy Nat Med 6 2000 482 483
54. P. Kovoor, K. Wickman, C.T. Maguire, W. Pu, J. Gehrmann, and C.I. Berul Evaluation of the role of I(KACh) in atrial fibrillation using a mouse knockout model J Am Coll Cardiol 37 2001 2136 2143
55. H. Niemann, and W.A. Kues Application of transgenesis in livestock for agriculture and biomedicine Anim Reprod Sci 79 2003 291 317
56. A.L. Waldo, W.A. MacLean, R.B. Karp, N.T. Kouchoukos, and T.N. James Entrainment and interruption of atrial flutter with atrial pacing: studies in man following open heart surgery Circulation 56 1977 737 745
57. L.H. Frame, R.L. Page, and B.F. Hoffman Atrial reentry around an anatomic barrier with a partially refractory excitable gap. A canine model of atrial flutter Circ Res 58 1986 495 511
58. A.L. Waldo Inter-relationships between atrial flutter and atrial fibrillation Pacing Clin Electrophysiol 26 2003 1583 1596
59. B. London Cardiac arrhythmias: from (transgenic) mice to men J Cardiovasc Electrophysiol 12 2001 1089 1991
60. V.T. Nguyen-Tran, S.W. Kubalak, S. Minamisawa, C. Fiset, K.C. Wollert, and A.B. Brown A novel genetic pathway for sudden cardiac death via defects in the transition between ventricular and conduction system cell lineages Cell 102 2000 671 682
61. B.A. VanderBrink, C. Sellitto, S. Saba, M.S. Link, W. Zhu, and M.K. Homoud Connexin40-deficient mice exhibit atrioventricular nodal and infra-Hisian conduction abnormalities J Cardiovasc Electrophysiol 11 2000 1270 1276
62. H. Gu, F.C. Smith, S.M. Taffet, and M. Delmar High incidence of cardiac malformations in connexin40-deficient mice Circ Res 93 2003 201 206
63. H. Kasahara, H. Wakimoto, M. Liu, C.T. Maguire, K.L. Converso, and T. Shioi Progressive atrioventricular conduction defects and heart failure in mice expressing a mutant Csx/Nkx2.5 homeoprotein J Clin Invest 108 2001 189 201
64. J.J. Schott, C. Alshinawi, F. Kyndt, V. Probst, T.M. Hoorntje, and M. Hulsbeek Cardiac conduction defects associate with mutations in SCN5A Nat Genet 23 1999 20 21
65. G.A. Papadatos, P.M. Wallerstein, C.E. Head, R. Ratcliff, P.A. Brady, and K. Benndorf Slowed conduction and ventricular tachycardia after targeted disruption of the cardiac sodium channel gene Scn5a Proc Natl Acad Sci U S A 99 2002 6210 6215
66. C.R. Bezzina, M.B. Rook, W.A. Groenewegen, L.J. Herfst, A.C. van der Wal, and J. Lam Compound heterozygosity for mutations (W156X and R225W) in SCN5A associated with severe cardiac conduction disturbances and degenerative changes in the conduction system Circ Res 92 2003 159 168
67. J.D. Brook, M.E. McCurrach, H.G. Harley, A.J. Buckler, D. Church, and H. Aburatani Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member Cell 69 1992 385
68. C.I. Berul, C.T. Maguire, M.J. Aronovitz, J. Greenwood, C. Miller, and J. Gehrmann DMPK dosage alterations result in atrioventricular conduction abnormalities in a mouse myotonic dystrophy model J Clin Invest 103 1999 R1 R7
69. M. Arad, D.W. Benson, A.R. Perez-Atayde, W.J. McKenna, E.A. Sparks, and R.J. Kanter Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy J Clin Invest 109 2002 357 362
70. M. Arad, I.P. Moskowitz, V.V. Patel, F. Ahmad, A.R. Perez-Atayde, and D.B. Sawyer Transgenic mice overexpressing mutant PRKAG2 define the cause of Wolff-Parkinson-White syndrome in glycogen storage cardiomyopathy Circulation 107 2003 2850 2856
71. S. Saba, B.A. VenderBrink, G. Perides, L.J. Glickstein, M.S. Link, and M.K. Homoud Cardiac conduction abnormalities in a mouse model of Lyme borreliosis J Interv Card Electrophysiol 5 2001 137 143
72. M.E. Miranda-Carus, M. Boutjdir, C.E. Tseng, F. DiDonato, E.K. Chan, and J.P. Buyon Induction of antibodies reactive with SSA/Ro-SSB/La and development of congenital heart block in a murine model J Immunol 161 1998 5886 5892
73. T.N. James, B.T. Robertson, A.L. Waldo, and C.E. Branch De subitaneis mortibus. XV. Hereditary stenosis of the His bundle in Pug dogs Circulation 52 1975 1152 1160
74. H. Garan, J.N. Ruskin, B. McGovern, and G. Grant Serial analysis of electrically induced ventricular arrhythmias in a canine model of myocardial infarction J Am Coll Cardiol 5 1985 1095 1196
75. J.S. Tweddell, C.K. Rokkas, A. Harada, J.S. Pirolo, B.H. Branham, and R.B. Schuessler Anterior septal coronary artery infarction in the canine: a model of ventricular tachycardia with a subendocardial origin. Ablation and activation sequence mapping Circulation 90 1994 2982 2992
76. D.S. Rosenbaum, D.J. Wilber, J.M. Smith, D. Du, J.N. Ruskin, and H. Garan Local activation variability during monomorphic ventricular tachycardia in the dog Cardiovasc Res 26 1992 237 243
77. N.S. Peters, and A.L. Wit Myocardial architecture and ventricular arrhythmogenesis Circulation 97 1998 1746 1754
78. C. Costeas, N.S. Peters, B. Waldecker, E.J. Ciaccio, A.L. Wit, and J. Coromilas Mechanisms causing sustained ventricular tachycardia with multiple QRS morphologies: results of mapping studies in the infarcted canine heart Circulation 96 1997 3721 3731
79. P.M. Patel, A. Plotnikov, P. Kanagaratnam, A. Shvilkin, C.T. Sheehan, and W. Xiong Altering ventricular activation remodels gap junction distribution in canine heart J Cardiovasc Electrophysiol 12 2001 570 577
80. D. Wrobleski, C. Houghtaling, M.E. Josephson, J.N. Ruskin, and V.Y. Reddy Use of electrogram characteristics during sinus rhythm to delineate the endocardial scar in a porcine model of healed myocardial infarction J Cardiovasc Electrophysiol 14 2003 524 529
81. V.Y. Reddy, Z.J. Malchano, G. Holmvang, E.J. Schmidt, A. d'Avila, and C. Houghtaling Integration of cardiac magnetic resonance imaging with three-dimensional electroanatomic mapping to guide left ventricular catheter manipulation: feasibility in a porcine model of healed myocardial infarction J Am Coll Cardiol 44 2004 2202 2213
82. A.A. Geisterfer-Lowrance, M. Christe, D.A. Conner, J.S. Ingwall, F.J. Schoen, and C.E. Seidman A mouse model of familial hypertrophic cardiomyopathy Science 272 1996 731 734
83. C.I. Berul, B.K. McConnell, H. Wakimoto, I.P. Moskowitz, C.T. Maguire, and C. Semsarian Ventricular arrhythmia vulnerability in cardiomyopathic mice with homozygous mutant Myosin-binding protein C gene Circulation 104 2001 2734 2739
84. D. Fatkin, C. MacRae, T. Sasaki, M.R. Wolff, M. Porcu, and M. Frenneaux Missense mutations in the rod domain of the lamin A/C gene as causes of dilated cardiomyopathy and conduction-system disease N Engl J Med 341 1999 1715 1724
85. L.C. Mounkes, S. Kozlov, L. Hernandez, T. Sullivan, and C.L. Stewart A progeroid syndrome in mice is caused by defects in A-type lamins Nature 423 2003 298 301
86. T. Arimura, A. Helbling-Leclerc, C. Massart, S. Varnous, F. Niel, and E. Lacene Mouse model carrying H222P-Lmna mutation develops muscular dystrophy and dilated cardiomyopathy similar to human striated muscle laminopathies Hum Mol Genet 14 2005 155 169
87. B. Gerull, A. Heuser, T. Wichter, M. Paul, C.T. Basson, and D.A. McDermott Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy Nat Genet 36 2004 1162 1164
88. K.S. Grossmann, C. Grund, J. Huelsken, M. Behrend, B. Erdmann, and W.W. Franke Requirement of plakophilin 2 for heart morphogenesis and cardiac junction formation J Cell Biol 167 2004 149 160
89. A. Sakamoto, K. Ono, M. Abe, G. Jasmin, T. Eki, and Y. Murakami Both hypertrophic and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex Proc Natl Acad Sci U S A 94 1997 13873 13878
90. N. Matsuoka, H. Arakawa, H. Kodama, and I. Yamaguchi Characterization of stress-induced sudden death in cardiomyopathic hamsters J Pharmacol Exp Ther 284 1998 125 135
91. C.J. Baty Feline hypertrophic cardiomyopathy: an update Vet Clin North Am Small Anim Pract 34 2004 1227 1234
92. I. Gussak, B.R. Chaitman, S.L. Kopecky, and J.M. Nerbonne Rapid ventricular repolarization in rodents: electrocardiographic manifestations, molecular mechanisms, and clinical insights J Electrocardiol 33 2000 159 170
93. J.M. Nerbonne Studying cardiac arrhythmias in the mouse-a reasonable model for probing mechanisms? Trends Cardiovasc Med 14 2004 83 93
94. J.M. Nerbonne, C.G. Nichols, T.L. Schwarz, and D. Escande Genetic manipulation of cardiac K(+) channel function in mice: what have we learned, and where do we go from here? Circ Res 89 2001 944 956
95. G. Koren Electrical remodeling and arrhythmias in long-QT syndrome: lessons from genetic models in mice Ann Med 36 Suppl 1 2004 22 27
96. M.P. Lee, J.D. Ravenel, R.J. Hu, L.R. Lustig, G. Tomaselli, and R.D. Berger Targeted disruption of the Kvlqt1 gene causes deafness and gastric hyperplasia in mice J Clin Invest 106 2000 1447 1455
97. S. Demolombe, G. Lande, F. Charpentier, M.A. van Roon, M.J. van den Hoff, and G. Toumaniantz Transgenic mice overexpressing human KvLQT1 dominant-negative isoform. Part I: phenotypic characterisation Cardiovasc Res 50 2001 314 327
98. F. Charpentier, J. Merot, D. Riochet, H. Le Marec, and D. Escande Adult KCNE1-knockout mice exhibit a mild cardiac cellular phenotype Biochem Biophys Res Commun 251 1998 806 810
99. R. Warth, and J. Barhanin The multifaceted phenotype of the knockout mouse for the KCNE1 potassium channel gene Am J Physiol Regul Integr Comp Physiol 282 2002 R639 R648
100. P. Babij, G.R. Askew, B. Nieuwenhuijsen, C.M. Su, T.R. Bridal, and B. Jow Inhibition of cardiac delayed rectifier K+ current by overexpression of the long-QT syndrome HERG G628S mutation in transgenic mice Circ Res 83 1998 668 678
101. J.P. Lees-Miller, J. Guo, J.R. Somers, D.E. Roach, R.S. Sheldon, and D.E. Rancourt Selective knockout of mouse ERG1 B potassium channel eliminates I(Kr) in adult ventricular myocytes and elicits episodes of abrupt sinus bradycardia Mol Cell Biol 23 2003 1856 1862
102. T. Hoorntje, M. Alders, P. van Tintelen, K. van der Lip, N. Sreeram, and A. van der Wal Homozygous premature truncation of the HERG protein:the human HERG knockout Circulation 100 1999 1264 1267
103. P.J. Mohler, I. Splawski, C. Napolitano, G. Bottelli, L. Sharpe, and K. Timothy A cardiac arrhythmia syndrome caused by loss of ankyrin-B function Proc Natl Acad Sci U S A 101 2004 9137 9142
104. J.J. Zaritsky, J.B. Redell, B.L. Tempel, and T.L. Schwarz The consequences of disrupting cardiac inwardly rectifying K(+) current (I(K1)) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes J Physiol 533 2001 697 710
105. J.J. Zaritsky, D.M. Eckman, G.C. Wellman, M.T. Nelson, and T.L. Schwarz Targeted disruption of Kir2.1 and Kir2.2 genes reveals the essential role of the inwardly rectifying K(+) current in K(+)-mediated vasodilation Circ Res 87 2000 160 166
106. C. Antzelevitch, G.X. Yan, and W. Shimizu Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome J Electrocardiol 32 Suppl 1999 158 165
107. S.G. Priori, C. Napolitano, N. Tiso, M. Memmi, G. Vignati, and R. Bloise Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia Circulation 103 2001 196 200
108. A.V. Postma, I. Denjoy, T.M. Hoorntje, J.M. Lupoglazoff, A. Da Costa, and P. Sebillon Absence of calsequestrin 2 causes severe forms of catecholaminergic polymorphic ventricular tachycardia Circ Res 91 2002 e21 e26
109. A.R. Marks, S. Priori, M. Memmi, K. Kontula, and P.J. Laitinen Involvement of the cardiac ryanodine receptor/calcium release channel in catecholaminergic polymorphic ventricular tachycardia J Cell Physiol 190 2002 1 6
110. X.H. Wehrens, S.E. Lehnart, F. Huang, J.A. Vest, S.R. Reiken, and P.J. Mohler FKBP12.6 deficiency and defective calcium release channel (ryanodine receptor) function linked to exercise-induced sudden cardiac death Cell 113 2003 829 840
111. M. Cerrone, B. Colombi, M. Santoro, M. Raffale di Barletta, M. Scelsi, and L. Villani Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor (RyR2) Circ Res 96 2005 e77 e82 Epub 2005
112. A.J. Camm, M.J. Janse, D.M. Roden, M.R. Rosen, J. Cinca, and S.M. Cobbe Congenital and acquired long QT syndrome Eur Heart J 21 2000 1232 1237
113. S. Zhang, Z. Zhou, Q. Gong, J.C. Makielski, and C.T. January Mechanism of block and identification of the verapamil binding domain to HERG potassium channels Circ Res 84 1999 989 998
114. Y. Alkan, W.E. Haefeli, J. Burhenne, J. Stein, I. Yaniv, and I. Shalit Voriconazole-induced QT interval prolongation and ventricular tachycardia: a non-concentration-dependent adverse effect Clin Infect Dis 39 2004 e49 e52
115. T. Yang, D. Snyders, and D.M. Roden Drug block of I(kr): model systems and relevance to human arrhythmias J Cardiovasc Pharmacol 38 2001 737 744
116. D.J. Milan, T.A. Peterson, J.N. Ruskin, R.T. Peterson, and C.A. MacRae Drugs that induce repolarization abnormalities cause bradycardia in zebrafish Circulation 107 2003 1355 1358
117. U. Langheinrich, G. Vacun, and T. Wagner Zebrafish embryos express an orthologue of HERG and are sensitive toward a range of QT-prolonging drugs inducing severe arrhythmia Toxicol Appl Pharmacol 193 2003 370 382